The decision on whether the Pharmaceutical Benefits Advisory Committee (PBAC) will place the drug Brentuximab Vedotin on the Pharmaceutical Benefits Scheme (PBS) will be announced Friday, April 24, and Member for Riverina, Michael McCormack weighed in on the topic.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
“The minister (Sussan Ley) has no control over which drugs are allowed to go through, the PBAC make that decision because they are the medical practitioners,” he said.
“I sympathise with Chris and his family, my family has been affected by it and I do understand it's an extremely tough situation for everyone involved."
Minister for Health and Sport, Sussan Ley did not wish to speak on the matter as it was currently before the independent PBAC and she felt it would be inappropriate to comment.
She was however “pleased to have met with Naomi and Chris Brugger to accept their petition and asked to be kept informed,” Ms Ley said.
